Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 3—March 2009


Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease

Muslim Atiq, Norah J. Shire, Anna Barrett, Susan D. Rouster, Kenneth E. Sherman, and Mohamed T. ShataComments to Author 
Author affiliations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (M. Atiq); University of Cincinnati College of Medicine, Cincinnati, Ohio, USA (N.J. Shire, A. Barrett, S.D. Rouster, K.E. Sherman, M.T. Shata)

Main Article

Table 2

Hepatitis E virus immunoglobulin G multivariable logistic regression results

Risk factor Adjusted odds ratio SEM p value 95% Confidence interval
Age 1.05 0.02 0.002 1.02–1.09
Male gender 2.07 0.07 0.009 1.17–3.66
History of chronic liver disease 7.78 3.25 0.001 3.43–17.64

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO